AI/ML Innovations to Acquire Quantum Sciences Ltd
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) has announced a share purchase agreement to acquire Quantum Sciences , a company focused on developing digital healthcare solutions using AI, machine learning, and quantum-inspired methodologies. The acquisition is valued at $690,000, to be paid through the issuance of 10 million common shares at $0.069 per share, reflecting a 25% discount to the 20-day VWAP on the CSE.
Quantum specializes in developing products and services that enhance healthcare trajectories and workflow efficiency through meaningful patient and care provider participation. The transaction is subject to CSE approval and customary closing conditions, with no new control persons being created and no significant debt being assumed.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) ha annunciato un accordo di acquisto azionario per acquisire Quantum Sciences, un'azienda focalizzata sullo sviluppo di soluzioni sanitarie digitali utilizzando AI, machine learning e metodologie ispirate al quantum. L'acquisizione è valutata 690.000 dollari, che saranno pagati tramite l'emissione di 10 milioni di azioni comuni a $0,069 per azione, riflettendo uno sconto del 25% rispetto al VWAP di 20 giorni sulla CSE.
Quantum è specializzata nello sviluppo di prodotti e servizi che migliorano i percorsi di cura e l'efficienza del flusso di lavoro attraverso una partecipazione significativa dei pazienti e dei fornitori di assistenza. La transazione è soggetta all'approvazione della CSE e alle condizioni di chiusura abituali, senza la creazione di nuovi soggetti di controllo e senza assumere debiti significativi.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) ha anunciado un acuerdo de compra de acciones para adquirir Quantum Sciences, una empresa centrada en el desarrollo de soluciones de salud digitales utilizando IA, aprendizaje automático y metodologías inspiradas en la mecánica cuántica. La adquisición está valorada en 690,000 dólares, que se pagarán a través de la emisión de 10 millones de acciones ordinarias a $0.069 por acción, reflejando un descuento del 25% respecto al VWAP de 20 días en la CSE.
Quantum se especializa en el desarrollo de productos y servicios que mejoran los trayectos de atención médica y la eficiencia del flujo de trabajo mediante la participación significativa de pacientes y proveedores de atención. La transacción está sujeta a la aprobación de la CSE y a las condiciones de cierre habituales, sin creación de nuevos personas de control y sin asumir deudas significativas.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)은 Quantum Sciences를 인수하기 위한 주식 매입 계약을 발표했습니다. Quantum Sciences는 AI, 머신러닝 및 양자 영감을 받은 방법론을 사용하여 디지털 헬스케어 솔루션을 개발하는 데 중점을 둔 회사입니다. 인수 금액은 690,000달러로, 주당 $0.069에 1,000만 보통주를 발행하여 지급됩니다. 이는 CSE에서 20일 간의 VWAP에 대해 25%의 할인을 반영합니다.
Quantum은 환자 및 치료 제공자의 의미 있는 참여를 통해 의료 경로 및 작업 효율성을 향상시키는 제품 및 서비스를 개발하는 데 특화되어 있습니다. 이번 거래는 CSE의 승인과 일반적인 마감 조건에 따라 진행되며, 새로운 통제인이 생성되지 않고 상당한 부채가 발생하지 않습니다.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) a annoncé un accord d'achat d'actions pour acquérir Quantum Sciences, une entreprise axée sur le développement de solutions de santé numériques utilisant l'IA, l'apprentissage automatique et des méthodologies inspirées de la mécanique quantique. L'acquisition est évaluée à 690 000 dollars, qui seront payés par l'émission de 10 millions d'actions ordinaires à 0,069 $ par action, ce qui reflète une réduction de 25 % par rapport au VWAP de 20 jours sur la CSE.
Quantum se spécialise dans le développement de produits et services qui améliorent les parcours de soins de santé et l'efficacité des flux de travail grâce à une participation significative des patients et des prestataires de soins. La transaction est soumise à l'approbation de la CSE et aux conditions de clôture habituelles, sans création de nouvelles personnes de contrôle et sans prise en charge de dettes significatives.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) hat eine Aktienkaufvereinbarung zur Übernahme von Quantum Sciences angekündigt, einem Unternehmen, das sich auf die Entwicklung digitaler Gesundheitslösungen unter Verwendung von KI, maschinellem Lernen und quanteninspirierten Methoden konzentriert. Der Wert der Übernahme beläuft sich auf 690.000 Dollar, die durch die Ausgabe von 10 Millionen Stammaktien zu einem Preis von 0,069 Dollar pro Aktie bezahlt werden, was einem Rabatt von 25 % auf den 20-Tage-VWAP an der CSE entspricht.
Quantum ist auf die Entwicklung von Produkten und Dienstleistungen spezialisiert, die die Gesundheitsverläufe und die Effizienz der Arbeitsabläufe durch die bedeutende Beteiligung von Patienten und Pflegeanbietern verbessern. Die Transaktion steht unter dem Vorbehalt der Genehmigung durch die CSE und der üblichen Abschlussbedingungen, ohne dass neue Kontrollpersonen geschaffen werden und ohne dass wesentliche Schulden übernommen werden.
- Strategic acquisition in digital healthcare solutions sector
- No significant debt assumption in the transaction
- Expansion of AI/ML capabilities in healthcare management
- Shares issued at 25% discount to market price, indicating potential dilution
- Transaction subject to regulatory approval and closing conditions
VICTORIA, BC / ACCESSWIRE / December 10, 2024 / AI/ML Innovations Inc. (the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that it has entered into an arms-length share purchase agreement dated December 9, 2024 (the "SPA") to acquire all of the issued and outstanding shares (the "Acquisition") of Quantum Sciences Ltd. ("Quantum"). Quantum currently carries on the business of designing transformative digital health care solutions utilizing artificial intelligence, machine learning and quantum inspired methodologies.
Specifically, Quantum is developing various products and services that enable meaningful participation of both patients and care providers to improve health care trajectories and enable more efficient and effective workflows.
The SPA contemplates a purchase price of
Paul Duffy, Chief Executive Officer of the Company, comments: "We are very pleased to be making the Acquisition of Quantum and to be working with their highly competent team of medical professionals as our team continues to chart a new path forward for AI/ML. We are looking forward to closing this acquisition and expect to be providing the market with updates on closing and other related matters in the near future".
On behalf of the Board of Directors
Tim Daniels, Chairman
About AI/ML Innovations Inc. https://aiml-innovations.com/
AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence: (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge Inc. (
For more information about AI/ML Innovations:
For detailed information please see AI/ML's website or the Company's filed documents at www.sedarplus.ca
For further information, contact: Blake Fallis at (778) 405-0882 or info@aiml-innovations.com
The Canadian Securities Exchange has in no way passed upon the merits of the Company and has neither approved nor disapproved the contents of this press release. Neither the Canadian Securities Exchange nor the Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. This press release contains "forward-looking statements" within the meaning of the securities laws. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates" and similar expressions or variations of such words are intended to identify forward-looking statements. Forward-looking statements are not historical facts, and are based upon management's current expectations, beliefs and projections, many of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no assurance that management's expectations, beliefs and projections will be achieved, and actual results may differ materially from what is expressed in or indicated by the forward-looking statements. In addition, we cannot assure that any patent will be issued as a result of a pending patent application or, if issued, whether it will be issued in a form that will be advantageous to us. Forward-looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward-looking statements. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company's reports filed from time to time at sedarplus.ca. Forward-looking statements speak only as of the date the statements are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances, changes in assumptions or changes in other factors affecting forward-looking information except to the extent required by applicable securities laws. If the Company does update one or more forward-looking statements, no inference should be drawn that the Company will make additional updates with respect thereto or with respect to other forward-looking statements. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. The Company is not responsible for the contents of third-party websites.
SOURCE: AI/ML Innovations, Inc.
View the original press release on accesswire.com
FAQ
What is the acquisition price for Quantum Sciences by AI/ML Innovations (AIMLF)?
What is the focus of Quantum Sciences' business being acquired by AIMLF?
When did AI/ML Innovations (AIMLF) announce the Quantum Sciences acquisition?
Will the Quantum Sciences acquisition create new control persons in AIMLF?
